Kamada Ltd.
MULTIPLE-VARIABLE DOSE REGIMEN FOR TREATING DIABETES

Abstract:

The present invention relates to the field of preservation of functional pancreatic islet (beta-cells) and treatment of diabetes, providing improved dosage regimen of AAT administration to Type 1 Diabetes Mellitus (T1DM) patients, particularly to newly diagnosed T1DM patients. The improved dose regiment is a multiple variable dosage regimen, comprising and induction phase and a treatment phase.